Mustafa Diken PhD
Biotechnology, Healthcare Management, Research and Clinical Research
Mainz, Rheinland-Pfalz, Germany
Connect with the speaker?
Dr. Mustafa Diken received his Ph.D. in tumor immunology from Johannes Gutenberg University, Mainz and is currently the Deputy Director of the Immunotherapy Development Center at TRON gGmbH. His research focuses on the development of novel cancer vaccines based on antigen-encoding messenger RNA (mRNA) and the elucidation of immunomodulatory mechanisms for cancer immunotherapy.
His other scientific interests include the use of non-invasive in vivo bioluminescence and fluorescence imaging techniques for preclinical testing of cancer vaccines. Dr. Diken also serves as the scientific secretary of the Association for Cancer Immunotherapy (CIMT), a non-profit organization aimed at advancing cancer immunotherapy.
His other scientific interests include the use of non-invasive in vivo bioluminescence and fluorescence imaging techniques for preclinical testing of cancer vaccines. Dr. Diken also serves as the scientific secretary of the Association for Cancer Immunotherapy (CIMT), a non-profit organization aimed at advancing cancer immunotherapy.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)
Quick Links
- 50 Division Street, Suite 501,
- Somerville, NJ 08876
- support@emedevents.com